Complement activation is associated with a variety of immunologically-mediated renal diseases. Proximal tubular epithelial cells in situ constitutively express messenger RNA for C4 of the complement system. These same epithelial cells in culture have been reported to contain message for C3 and to secrete this protein when stimulated by IL-2. The present study compared the in situ localization of C3 and C4 message in parallel in a variety of renal biopsy and nephrectomy specimens. All adequate tissue samples (n = 23) had C4 mRNA throughout in the cortical tubular epithelium. Although C3 message was also expressed in tubular epithelial cells, there was much greater variation in its distribution. mRNA for C3 was not detected in histologically normal specimens (n = 4) either by in situ or Northern hybridization. Focal C3 message correlated with focal histologic abnormalities (e.g., focal glomerulosclerosis), while more generalized C3 signal occurred in specimens with more diffuse inflammatory processes (e.g., SLE). Infiltrating inflammatory cells and cells of the glomeruli were uniformly negative for C3 (and C4) message. Tubular C3 and C4 mRNA appeared to be translated, since selected specimens showed cytoplasmic staining by monoclonal antibodies to C3c and C4c. These observations are consistent with the hypothesis that local production of inflammatory mediators could induce C3 synthesis in the renal interstitium, with the possibility that subsequent complement activation could enhance the pathogenic process.
T R Welch, L S Beischel, D P Witte
Title and authors | Publication | Year |
---|---|---|
Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics
Tilo Freiwald, Behdad Afzali |
Advances in immunology | 2021 |
Leptospiral Immunoglobulin-Like Domain Proteins: Roles in Virulence and Immunity
DA Haake, J Matsunaga |
Frontiers in immunology | 2021 |
Establishing a Case for Anti-complement Therapy in Membranous Nephropathy
I Ayoub, JP Shapiro, H Song, XL Zhang, S Parikh, S Almaani, S Madhavan, SV Brodsky, A Satoskar, C Bott, L Yu, M Merchant, J Klein, JM Mejia-Vilet, T Nadasdy, D Birmingham, BH Rovin |
Kidney International Reports | 2021 |
Expanding the Role of Complement Therapies: The Case for Lupus Nephritis
NL Li, DJ Birmingham, BH Rovin |
Journal of Clinical Medicine | 2021 |